Noveome Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues. The Company has developed ST266, a complex non-cellular product containing hundreds of biologically active proteins and other biologic factors.